Enhanced migraine treatments based on ghrelin mimetics

Details for Australian Patent Application No. 2010217792 (hide)

Owner Helsinn Therapeutics (U.S.), Inc.

Inventors Polvino, William J.

Agent Spruson & Ferguson

Pub. Number AU-A-2010217792

PCT Pub. Number WO2010/099522

Priority 61/156,129 27.02.09 US

Filing date 1 March 2010

Wipo publication date 2 September 2010

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/00 (2006.01)

A61K 31/4045 (2006.01)

A61K 31/4164 (2006.01) - 1,3-Diazoles

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/099522 Priority application(s): WO2010/099522

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010217794-Yeast with increased butanol tolerance involving a multidrug efflux pump gene

2010217786-Segmented fresnel solar concentrator